Optogenetics is a biological technique that uses light to control neurons that have been genetically modified to express light-sensitive ion channels (opsins). By delivering light through optical fibers to specific brain regions, researchers can activate or silence genetically defined cell populations with millisecond temporal precision, enabling causal investigation of neural circuit function with a specificity impossible with electrical stimulation.
Since the first demonstration of reliable optogenetic control of mammalian neurons in 2005, the technique has transformed systems neuroscience by enabling precise manipulation of identified cell types during behavior. Applications span sensory processing, motor control, learning and memory, reward circuits, and social behavior. The development of diverse opsin variants with different spectral sensitivities, kinetics, and ionic selectivities has expanded the experimental toolkit for bidirectional circuit interrogation.
Translation of optogenetics to clinical applications faces challenges including the requirement for viral gene delivery to express opsins in human neurons, the need for chronic implantable light delivery systems, and safety and regulatory considerations surrounding genetic modification of brain tissue. Nonetheless, optogenetic approaches to vision restoration in retinal degeneration have advanced to clinical trials, and the technology continues to drive fundamental discoveries about brain circuit organization that inform the development of other neurotechnologies.